Product
OGIVRI
Aliases
trastuzumab-dkst
Name
OGIVRI
INN Name
trastuzumab-dkst
FDA Approved
Yes
2 organizations
1 indication
1 document
Indication
Gastric CancerOrganization
Mylan Institutional LLCDocument
DailyMed Label: OGIVRIOrganization
Biocon Biologics Inc.